| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | 0.04 | 0.8 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | 0.046 | 0.8 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.8 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.0068 | 0.8 |